To study and compare blood tests and cut specimens in patients of colorectal cancer.
Not Applicable
- Conditions
- Health Condition 1: C189- Malignant neoplasm of colon, unspecified
- Registration Number
- CTRI/2024/07/069979
- Lead Sponsor
- Datta Meghe Institute of Higher Education and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
•Patients with a diagnosis confirmed through histopathological examination.
•Patients with colorectal carcinoma that has originated de novo (without prior related history).
•Primary cases of colorectal carcinoma with no history of previous treatment.
•Patients who are not taking lipid-lowering medications.
Exclusion Criteria
•Patients who are taking lipid-lowering medications.
•Patients who are receiving neoadjuvant chemotherapy for colorectal carcinoma.
•Patients who have previously undergone surgical procedures for colorectal cancer before being enrolled in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum lipid levels will be lower and CEA levels will be higher in comparison to various stages of colorectal carcinoma.Timepoint: Assessment will be done at 12 months.
- Secondary Outcome Measures
Name Time Method ILTimepoint: NA